LOTEPREDNOL ETABONATE
Generic: LOTEPREDNOL ETABONATE
ARMAS PHARMACEUTICALS INC.Manufacturer
OPHTHALMICRoute
LOTEPREDNOL ETABONATEActive Substance
2023-04-12Original Approval
LOTEPREDNOL ETABONATE is FDA application ANDA215933, sponsored by SENTISS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
EYE PAIN
142 reports
2
EYE IRRITATION
88 reports
3
DRUG INEFFECTIVE
52 reports
4
OFF LABEL USE
52 reports
5
HEADACHE
46 reports
6
OCULAR HYPERAEMIA
42 reports
7
PHOTOPHOBIA
40 reports
8
FATIGUE
37 reports
9
EYE SWELLING
35 reports
10
PRODUCT DOSE OMISSION ISSUE
34 reports